Northeast Georgia's Medical Center Gainesville's Level I Trauma Center researchers are participating in an international clinical trial that studies how a device could increase trauma patients’ chances of survival.
According to a press release from the medical center, NGMC Gainesville was among eight leading Level I trauma centers chosen to participate across the United States and Canada.
The trauma team at NGMC Gainesville already performs partial resuscitative balloon occlusion of the aorta – also known as Partial REBOA –to help stop a patient’s internal bleeding through a device called pREBOA-PRO. However, now, the team will take part in the clinical trial PROMPT (Partial REBOA Outcomes Multicenter ProspecTive) Study, and share data on the use of the device
“No one should bleed to death – and the sooner we can stop the bleeding, the better,” Matthew Vassy, MD, medical director of trauma at NGMC, said. “Time is of the essence for trauma patients, and this PROMPT study should give us compelling data to improve how we save lives.”
The PROMPT study will provide those in the trauma field with in-depth data about the device's performance by enrolling 340 patients in two years across all eight selected centers.
The center says NGMC patients who match the study criteria will be automatically enrolled in the study this spring. Learn more about NGMC's trauma program at nghs.com/trauma.
